Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Schreiber Alain
Relationship:   10% Owner
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   12,051,047    

Indirect Shares

   11,491,339      
Direct Value   $27,342,535    

Indirect Value

   $2,610,128      
Total Shares   23,542,386      
Total Value   $29,952,663      


Molecular Templates, Inc. $81,877 Palatin Technologies Inc $10,853,428 Cadence Pharmaceuticals Inc $0 Optimer Pharmaceuticals Inc $0 Immune Design Corp. $0 Urogen Pharma Ltd. $16,407,230 Molecular Templates, Inc. $81,877 Palatin Technologies Inc $10,853,428 Cadence Pharmaceuticals Inc $0 Optimer Pharmaceuticals Inc $0 Immune Design Corp. $0 Urogen Pharma Ltd. $16,407,230
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Molecular Templates, Inc. MTEM 10% Owner 2005-10-28 136,417 2005-10-28 3,385,203    Premium*  
            Palatin Technologies Inc PTN 10% Owner 2005-11-29 5,803,972 2005-11-29 0    Premium*  
            Cadence Pharmaceuticals Inc CADX Director, 10% Owner 2007-09-19 2,882,269 2006-10-30 12,500    Premium*  
            Optimer Pharmaceuticals Inc OPTR Director 2008-07-18 2,500 2009-03-04 811,998    Premium*  
            Avanir Pharmaceuticals AVNR 10% Owner 2008-08-06 0 2009-10-13 7,125,754    Premium*  
            Eagle Pharmaceuticals, Inc. EGRX 10% Owner 0 2017-05-15 155,884    Premium*  
            Immune Design Corp. IMDZ 10% Owner 2015-05-12 1,983,858 2015-03-05 0    Premium*  
            Urogen Pharma Ltd. URGN 10% Owner 2017-11-28 1,242,031 0    Premium*  
* Premium Members only  

Records found :    117         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-03-30 4 S $83.00 $516,509 I/I (6,223) 3,669,196 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-03-28 4 S $83.02 $513,230 I/I (6,182) 3,734,174 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-03-23 4 S $83.01 $58,107 I/I (700) 3,778,087 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-03-21 4 S $83.10 $41,550 I/I (500) 3,778,787 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-03-20 4 S $82.10 $4,259,594 I/I (51,883) 3,779,287 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-03-17 4 S $82.01 $3,198,144 I/I (38,997) 3,831,170 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-03-16 4 S $82.08 $748,570 I/I (9,120) 3,870,167 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-01-04 4 S $85.16 $5,545,108 I/I (65,114) 3,879,287 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2016-11-11 4 S $85.00 $1,321,835 I/I (15,551) 3,944,401 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2016-11-09 4 S $75.70 $11,818,065 I/I (148,800) 3,977,287 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2016-11-07 4 S $75.39 $379,212 I/I (5,030) 4,126,087 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2016-11-04 4 S $75.00 $3,462,750 I/I (46,170) 4,181,446 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2016-09-30 4 S $70.06 $1,548,326 I/I (22,100) 4,373,987 0 -
EGRX Eagle Pharmaceuticals, In... Director   –       •       •   2014-02-18 4 B $15.00 $4,999,995 I/I 333,333 4,770,828 2.25 -
EGRX Eagle Pharmaceuticals, In... Director   –       •       •   2014-02-18 4 B $15.00 $4,999,995 I/I 333,333 4,770,828 2.25 -
PTN Palatin Technologies Inc officerTitle   –       –       •   2005-11-29 4 S $3.90 $1,402,318 D/D (358,000) 5,803,972 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2009-10-13 4 S $2.23 $1,220,111 I/I (547,135) 7,125,754 0 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2009-10-12 4 S $2.12 $905,547 I/I (427,145) 7,672,889 0 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-08-05 3 IO $0.00 $0 I/I 0 7,820,470 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-08-06 4 B $0.90 $360 I/I 400 7,820,870 1.42 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-08-07 4 B $0.98 $89,552 I/I 91,380 7,912,250 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-08-14 4 B $0.90 $5,446 I/I 6,051 7,918,301 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-08-15 4 B $0.95 $108,330 I/I 114,032 8,032,333 1.5 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2009-10-09 4 S $2.46 $1,979,592 I/I (804,712) 8,100,034 0 -
AVNR Avanir Pharmaceuticals 10% Owner   –       –       •   2008-08-27 4 B $0.95 $84,975 I/I 89,447 8,121,780 1.5 -
  117  Records found
  1   2   3   4  5      
  Page 4 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us